Insulin analogue usage in a haemodialysis patient with type 2 diabetes mellitus [8]

Nephrology Dialysis Transplantation

Volumn 21, Issue 2, 2006, Pages 553-554

  Ersoy, Alpaslan ^a   Ersoy, Canan ^a   Altinay, Tumay ^a  

^a ULUDAG UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; INSULIN DERIVATIVE; INSULIN GLARGINE; INSULIN LISPRO; ISOPHANE INSULIN; LONG ACTING DRUG;

ADULT; CASE REPORT; CLINICAL FEATURE; DRUG COST; DRUG DOSE REGIMEN; FEMALE; GLUCOSE HOMEOSTASIS; HEMODIALYSIS; HUMAN; HYPERINSULINEMIA; HYPOGLYCEMIA; INSULIN TREATMENT; KIDNEY FAILURE; LETTER; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL;

DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; KIDNEY FAILURE, CHRONIC; MIDDLE AGED; RENAL DIALYSIS;

EID: 31544464630     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfi205     Document Type: Letter

References (5)

1. Snyder RW, Berns JS. Use of insulin and oral hypoglycemic medications in patients with diabetes mellitus and advanced kidney disease. Semin Dial 2004; 17: 365-370
2. Mayfield JA, White RD. Insulin therapy for type 2 diabetes: Rescue, augmentation, and replacement of beta-cell function. Am Fam Physician 2004; 70: 489-500
3. Amico JA, Klein I. Diabetic management in patients with renal failure. Diabetes Care 1981; 4: 430-434
4. Hirsch IB. Insulin analogues. N Engl J Med 2005; 352: 174-183
5. Aisenpreis U, Pfutzner A, Giehl M, Keller F, Jehle PM. Pharmacokinetics and pharmacodynamics of insulin Lispro compared with regular insulin in haemodialysis patients with diabetes mellitus. Nephrol Dial Transplant 1999; 14 [Suppl 4]: 5-6